The turning point
Al’s doubts, and the team’s initial challenges, stemmed mainly from the automation layer, which required a significant learning curve. Getting decontamination cycles, sensors, and reporting fully dialed in took roughly a year to a year and a half, he says, with SKAN providing hands-on support along the way.
Al’s conversion to advocate happened once he saw the results of the Aseptic Processing Simulations (APS) in the isolator.
Back when batches were processed in a BSC, he says, sterility failures were a recurring reality. That meant 20 days of production, all down the drain. “You already spent the money, you already made the batch, and then—gone, just like that,” he recalls.
After they made the switch, across 14 APS runs, only two resulted in failure—both traced to contaminated media from a supplier, not to the isolator itself. Once they changed that supplier, the failures stopped entirely.